Antibiotic candidate, dalbavancin, designated as a Qualified Infectious Disease Product by the FDA

The intravenous antibiotic product candidate, dalbavancin,  has been designated as a Qualified Infectious Disease Product (QIDP) by the Food and Drug Administration (FDA), making it eligible for fast-track status, More...